Fig. 2From: Measurement of anti-DFS70 antibodies in patients with ANA-associated autoimmune rheumatic diseases suspicion is cost-effectiveDifferences in number of ANA IIF, anti-dsDNA and ENA determinations between the conventional and the new algorithm. (***p < 0.001; **p < 0.01; *p < 0.05; NS not significant)Back to article page